Ozempic (semaglutide)

Product Name:

Ozempic (semaglutide)

Categories: Diabetes, Endocrinology, Metabolism

Discover Savings on Your Medication Access

Trusted concierge service, secure process, and real savings for patients in the U.S.

Table of Contents

Ozempic (semaglutide)

Product Category

Once-weekly injectable GLP-1 receptor agonist for type 2 diabetes and weight management

Brand Name

Ozempic

Generic Name or Biosimilar

Semaglutide (no biosimilars currently available)

Active Ingredient

Semaglutide

Prescription Status

Prescription-only (Rx)

Targeted Conditions

  • Type 2 diabetes in adults (to improve blood sugar control)
  • To reduce risk of major cardiovascular events in adults with type 2 diabetes and known heart disease
  • Weight loss and obesity management (off-label)

Ozempic is a powerful option for patients needing glucose control, cardiovascular risk reduction, and for those who may benefit from significant weight loss.

Off-Label Usage

  • Weight loss in non-diabetics
  • Obesity or metabolic syndrome
  • Polycystic ovary syndrome (PCOS)
  • Prediabetes in high-risk individuals

Off-label use is common and should be guided by a healthcare professional with experience in metabolic disease.

Drug Classification Overview

Ozempic is a GLP-1 receptor agonist that mimics the action of the GLP-1 hormone. It stimulates insulin secretion, suppresses glucagon, slows gastric emptying, helps with appetite control, and reduces blood sugar levels and cardiovascular risk.

Manufacturer in the USA and Manufacturer in Mexico

USA: Novo Nordisk, Inc.
Mexico: Novo Nordisk México, S.A. de C.V.

Available Strengths and Dosage Forms – United States

  • Prefilled pens: 0.25 mg, 0.5 mg, 1 mg, 2 mg
  • Once-weekly subcutaneous injection

Available Strengths and Dosage Forms – Mexico

  • Identical to U.S. versions: 0.25 mg, 0.5 mg, 1 mg, 2 mg pens
  • Available in retail pharmacies and through diabetes clinics

Country Comparison – United States vs. Mexico

  • Same manufacturer, quality, and dosage
  • FDA- and COFEPRIS-regulated
  • Significant savings for out-of-pocket patients in Mexico

Average Retail Price (Monthly Treatment) USA vs. Mexico

Country Price per Month
USA $900–$1,100 USD
Mexico $250–$450 USD

Actual price varies by pharmacy, dose, and region.

Where to Buy USA

  • Available by prescription at retail and specialty pharmacies
  • Insurance or prior authorization may be needed for coverage

Storage Requirements

  • Refrigerate before use (2°C–8°C / 36°F–46°F)
  • Once in use, store at room temperature (below 30°C/86°F) for up to 56 days
  • Do not freeze or expose to heat or sunlight

Shipping

  • Available in Mexico via MedicalMex partner clinics and pharmacies
  • Patients receive full consultation and support

Key Benefits

  • Lowers blood sugar (A1C) in type 2 diabetes
  • Reduces risk of major cardiovascular events
  • Clinically proven weight loss
  • Once-weekly dosing, no daily pills
  • No risk of hypoglycemia when used alone
  • Helps control appetite and cravings
  • Supports metabolic health in at-risk patients

Ozempic is a leading choice for modern diabetes and weight management, with proven cardiovascular and metabolic benefits.

Usage Instructions

  • Inject once weekly under the skin (abdomen, thigh, upper arm)
  • Start at 0.25 mg weekly for 4 weeks, then increase as directed
  • Doses may be raised to 0.5 mg, 1 mg, or 2 mg weekly
  • Use at the same time each week (with or without food)
  • Rotate injection sites to prevent skin irritation

Side Effects

  • Nausea, vomiting, diarrhea or constipation
  • Loss of appetite
  • Fatigue or headache
  • Rare: pancreatitis, gallbladder problems, kidney injury, allergic reactions
  • Increased risk of thyroid tumors in animal studies (not seen in humans)

Side effects are often mild and improve with time. Notify your doctor if symptoms persist or are severe.

Warnings and Precautions

  • Not for type 1 diabetes or diabetic ketoacidosis
  • Avoid in patients with history of medullary thyroid cancer or MEN 2 syndrome
  • Caution in severe gastrointestinal disease or history of pancreatitis
  • May delay absorption of oral medications
  • Not recommended during pregnancy or breastfeeding
  • Stay hydrated, especially during initial treatment

Alternative Medications (by Indication)

For type 2 diabetes or weight loss:

  • Mounjaro (tirzepatide) – dual GLP-1/GIP agonist
  • Rybelsus (oral semaglutide) – daily pill
  • Trulicity (dulaglutide) – weekly GLP-1 injection
  • Victoza (liraglutide) – daily GLP-1 injection
  • Wegovy (semaglutide) – higher-dose version for weight loss
  • Metformin – oral glucose control
  • Insulin therapies – for advanced cases

Medication FAQs

Ozempic (semaglutide)

No. Ozempic is a GLP-1 receptor agonist, not insulin. It helps your body produce insulin more effectively when blood sugar rises.

Yes. Many people lose weight on Ozempic, even when used for type 2 diabetes. Weight loss is a well-documented benefit, though not its primary indication.

Blood sugar control can improve within 1–2 weeks. Weight loss may begin after several weeks and continues gradually.

Ozempic works best with a healthy, reduced-calorie diet and regular exercise. Your provider may recommend a tailored plan.

It is approved for type 2 diabetes, but is used off-label for weight loss in overweight or obese patients under medical supervision.

Take the missed dose as soon as you remember unless it’s been more than 5 days. If so, skip the missed dose and resume your regular schedule.

Some patients regain weight without lifestyle changes. Long-term management may be needed for sustained results.

No. Ozempic is not recommended during pregnancy or breastfeeding. Consult your doctor if you are planning pregnancy.

Rarely when used alone. Risk increases if combined with insulin or sulfonylureas. Monitor closely if on multiple therapies.

Yes. Ozempic is widely available in Mexico through certified providers and is often more affordable than in the U.S.

Weight loss varies, but clinical studies show 8–14 pounds (3.5–6.5 kg) in six months on average. Higher doses and lifestyle changes improve outcomes.

Both contain semaglutide. Ozempic is for diabetes, Wegovy is approved specifically for weight loss at higher doses.

Many doctors prescribe Ozempic off-label for PCOS to help with weight, insulin resistance, and metabolic symptoms.

Moderate alcohol is generally allowed, but it may worsen side effects and interfere with blood sugar control.

Yes. Doctors may monitor A1C, blood sugar, kidney, and pancreatic function periodically.

Ozempic can be continued long-term for diabetes or weight management as long as it’s effective and well tolerated.